Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer Part I. Conventional chemotherapeutic drugs
Claire Marie Reyes-Habito, MD,a and Ellen K. Roh, MDb Laguna, Philippines, and Boston, Massachusetts
Roberta Lanzillo, Multiple Sclerosis Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Via Pansini 5, Napoli, 80131, Italy.
Multiple Sclerosis Journal, 1–2, DOI: 10.1177/1352458514562989
© The Author(s), 2015.
Reprints and permissions:
Int J MS Care 2006; 8 (Supplement 1).
Drug Saf 2000; 22: 149–159.